Johnson & Johnson: Tom Kavanagh will succeed Jennifer Taubert as Executive Vice President and Global Chairman of the Innovative Drugs Division.

Zhitongcaijing · 08/04 12:49
Johnson & Johnson: Tom Kavanagh will succeed Jennifer Taubert as Executive Vice President and Global Chairman of the Innovative Drugs Division.